2019

Is clinical trial transparency under threat?

REBRAND: Fact or Fiction publication

An insightful day at the EURIPID stakeholder meeting in Budapest

Halving snakebite deaths and disabilities by 2030 – How can we reach WHO’s goal?

Gender mainstreaming, sustainability and the future of HSA: Partners gather in Kenya for the JAP 2019

A Momentous Week for Access to Medicines

Working together to end the suffering of pregnant women and families – Photo Essay

Access to ICEMs is a fundamental human right, but millions aren’t receiving them

Welcome to the new look website!

Dr Marg Ewen Receives the Helen Clark-JoPPP Award

Staff Spotlight: Jessica Davy

No Universal Health Coverage without Universal Medicines Coverage

2018

Our European Projects Highlights for 2018

A Year at the Heart of Regulatory Decision Making

HAI and Snakebite Programme Partner, James Ashe Antivenom Trust, Applaud Government Action on Antivenom at Bio-Ken Snakebite Symposium

Staff Spotlight: Sabrina Hennecke

Staff Spotlight: Jaume Vidal

Time for a Treaty? ReAct Reports on Second Consultation on Global Development & Stewardship Framework to Combat AMR

Medicijnen: de link met de maatschappij

What Role Can Civil Society Play in the European Regulatory Process?

On the Road in Kilifi County: HAI Launches Snakebite Programme in Kenya

Open Science for Health: Shaping the New Framework Programme

2017

EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines

The Forgotten Victims of Snakebite

New Dutch Government Must Ensure Transparency to Control Medicine Prices

Staff Spotlight: Tim Reed

Giving Snakebite Victims a Voice

HAI’s Research into Access to Sexual and Reproductive Health Commodities Now in Full Swing

Staff Spotlight: Gemma Buckland-Merrett

Staff Spotlight: Mieke Bakx